SCHEMBL7179799

SCHEMBL7179799

CNc1ccc(C(=O)/C=C/c2c(OC(C)C)ccc(C)c2OC(C)C)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABCG2 Q9UNQ0 4/20 0.40
PDE4A P27815 1/20 0.40
PDE4B Q07343 1/20 0.40
PDE4C Q08493 1/20 0.40
PDE4D Q08499 1/20 0.40
CYP3A4 P08684 1/20 0.38
MEN1 O00255 3/20 0.37
KMT2A Q03164 3/20 0.37
SMN1; SMN2 Q16637 2/20 0.37
LMNA P02545 2/20 0.37
NPSR1 Q6W5P4 2/20 0.37
HPGD P15428 1/20 0.37
MAPT P10636 4/20 0.36
NPC1 O15118 2/20 0.36
RAB9A P51151 2/20 0.36
GAA P10253 1/20 0.36
ALDH1A1 P00352 1/20 0.36
MAPK1 P28482 1/20 0.36
RECQL P46063 1/20 0.36
TDP1 Q9NUW8 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7179804 1.00 ABCG2 (0.40) ABCG2PDE4APDE4BPDE4CPDE4D
SCHEMBL7190678 0.86 CAPN1 (0.47) ABCG2PDE4APDE4BPDE4CPDE4D
SCHEMBL7190676 0.86 CAPN1 (0.47) ABCG2PDE4APDE4BPDE4CPDE4D
SCHEMBL7192538 0.86 PDE4A (0.38) ABCG2PDE4APDE4BPDE4CPDE4D
SCHEMBL7192535 0.86 PDE4A (0.38) ABCG2PDE4APDE4BPDE4CPDE4D
SCHEMBL7184482 0.85 CA1 (0.47) ABCG2PDE4APDE4BPDE4CPDE4D
SCHEMBL7184488 0.85 CA1 (0.47) ABCG2PDE4APDE4BPDE4CPDE4D
SCHEMBL7189351 0.85 ABCG2 (0.57) ABCG2PDE4APDE4BPDE4CPDE4D
SCHEMBL7189354 0.85 ABCG2 (0.57) ABCG2PDE4APDE4BPDE4CPDE4D
SCHEMBL7187869 0.85 PDE4A (0.36) ABCG2PDE4APDE4BPDE4CPDE4D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6603046-B1 The invention is drawn to novel bis-aromatic a, beta -unsaturated ketones. The compounds are useful in the treatment and prophylaxis of diseases caused by parasites or bacteria. LICA PHARMACEUTICALS A/S (DK) 2003-08-05 US disclosed
EP-0634927-B1 TREATMENT AND PROPHYLAXIS OF DISEASES CAUSED BY PARASITES, OR BACTERIA LICA PHARMACEUTICALS AS (DK) 2001-07-04 EP disclosed
US-5985935-A PARASITICIDES OR BACTERICIDES STATENS SERUMINSTITUT (DK) 1999-11-16 US disclosed
EP-0634927-A1 TREATMENT AND PROPHYLAXIS OF DISEASES CAUSED BY PARASITES, OR BACTERIA STATENS SERUMINSTITUT (DK) 1995-01-25 EP disclosed
WO-1993017671-A1 TREATMENT AND PROPHYLAXIS OF DISEASES CAUSED BY PARASITES, OR BACTERIA STATENS SERUMINSTITUT (DK) 1993-09-16 WO disclosed